A single-injection vaccine for the polio virus
Nanoparticles could offer a new way to help eradicate the disease worldwide...
List view / Grid view
News
Innovative light-delivery technique improves biosensors
An innovative way to inject light into tiny silicon microdisks could help meet the need for practical chip-based sensors to detect cancer and other diseases.
Artificial Intelligence improves stroke and dementia diagnosis in CT brain scan
Machine learning has detected one of the commonest causes of dementia and stroke, in the most widely used form of brain scan (CT), more accurately than current methods.
CBD significantly reduces seizures in patients with severe epilepsy
Cannabidiol was shown in a new large-scale, randomised, controlled trial to significantly reduce the number of dangerous seizures in patients with a severe form of epilepsy...
Arthritis drugs potentially safe for expectant mothers
Pregnant mothers may use rheumatoid arthritis drugs without increased health risks to unborn baby...
TXA may benefit stroke patients
Patients with stroke caused by bleeding on the brain may benefit from receiving a drug currently used to treat blood loss from major trauma and bleeding after childbirth...
Algenuity appoints new Chief Scientific Officer
Algenuity, a leader in algal biology and industrial biotechnology, is delighted to welcome Dr Alex Pudney to the team as Chief Scientific Officer...
Anticancer drug nintedanib found to be effective against malignant pleural mesothelioma
Researchers have found that nintedanib shows promising effectiveness in halting the growth of human malignant pleural mesothelioma in preclinical models.
NIH funds three national cryo-EM service centres and training for new microscopists
The NIH is supporting efforts to broaden biomedical scientists’ access to cryo-electron microscopy, the imaging method that is revolutionising structural biology...
Diabetes drugs show promise to treat symptoms of Alzheimer’s
Discovery of a pathway linking Alzheimer's disease and Type 2 diabetes leads to new strategies to preserve brain health...
FDA approves first epoetin alfa biosimilar for the treatment of anaemia
The FDA has approved Retacrit as a biosimilar to Epogen/Procrit for the treatment of anaemia caused by chronic kidney disease, chemotherapy, or use of zidovudine in patients with HIV infection...
Web tool predicts phenotypes from a DNA sample
An international team of scientists have developed a novel tool to accurately predict eye, hair and skin colour from human biological material...
SB216763 shows efficacy in Rett syndrome
Researchers describe how a new drug is able to reduce the symptoms and activate the dormant neurons characteristic of Rett Syndrome...
New molecule to improve pharmaceuticals draws inspiration from nature’s toolbox
New catalyst is specifically tuned to integrate fluorine atoms into a new organic product...
FDA expands approval of Gilenya to treat multiple sclerosis in paediatric patients
The FDA has approved Gilenya to treat relapsing multiple sclerosis in children and adolescents age 10 years and older...
